Kavita Aggarwal
Chief Tech/Sci/R&D Officer at VERONA PHARMA PLC
Kavita Aggarwal active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VERONA PHARMA PLC | Chief Tech/Sci/R&D Officer | 2022-12-31 | - |
Career history of Kavita Aggarwal
Former positions of Kavita Aggarwal
| Companies | Position | Start | End |
|---|---|---|---|
| DOVA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - | - |
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Training of Kavita Aggarwal
| North Carolina State University | Undergraduate Degree |
| University of North Carolina at Chapel Hill | Doctorate Degree |
Statistics
International
| United States | 5 |
| United Kingdom | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| VERONA PHARMA PLC | Health Technology |
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Kavita Aggarwal
- Experience
